NCT00604032View on ClinicalTrials.gov

Study to Determine the Phototoxity of Atralin (Tretinoin) Gel, 0.05%

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

January 31, 2008

Study Completion Date

February 29, 2008

Conditions
Healthy
Interventions
DRUG

Atralin (tretinoin) Gel, 0.05%

Assess potential of tretinoin gel, 0.05% to produce phototoxic reactions, measured 24 and 48 hours after UV radiation of drug on the skin.

Trial Locations (1)

27106

Suncare Research Laboratories, Winston-Salem

Sponsors
All Listed Sponsors
lead

Coria Laboratories, Ltd.

INDUSTRY